Safety, Tolerability, and Preliminary Efficacy of Serplulimab, a Novel Anti-PD-1 Antibody, in Patients with Metastatic or Recurrent Solid Tumors: A Phase I Study
Authors (first, second and last of 4)
Collection
Immune Checkpoint Inhibitors in Oncology
A collection of recent articles on immune checkpoint inhibitors for cancer therapy.
Articles (20 in this collection)
-
-
Immunotherapy Guided by Immunohistochemistry PD-L1 Testing for Patients with NSCLC: A Microsimulation Model-Based Effectiveness and Cost-Effectiveness Analysis
Authors (first, second and last of 4)
-
-
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma
Authors (first, second and last of 11)
-
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing
Authors (first, second and last of 4)
-
-
Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy
Authors
-
-
First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data
Authors (first, second and last of 4)
-
Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?
Authors (first, second and last of 4)
-
-
Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges
Authors (first, second and last of 4)
-
-
Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
Authors (first, second and last of 5)
-
-
First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors
Authors (first, second and last of 6)
-
-
-
-
